Intralesional antibiotic injection using 41G needle for the management of subretinal abscess in endogenous endophthalmitis by unknown
Venkatesh et al. Int J Retin Vitr  (2016) 2:17 
DOI 10.1186/s40942-016-0043-x
CASE REPORT
Intralesional antibiotic injection using 
41G needle for the management of subretinal 
abscess in endogenous endophthalmitis
Pradeep Venkatesh* , Shreys Temkar, Koushik Tripathy and Rohan Chawla
Abstract 
Background: Presence of subretinal abscess in endogenous endophthalmitis indicates a more severe form of infec‑
tion. Available reports indicate variable response to standard treatment with systemic, intravitreal pharmacotherapy 
and vitreous surgery. There are no reports citing the possible role of intralesional antibiotic therapy in managing 
subretinal abscess.
Case presentation: A 30 year old lady presented with features of endogenous endophthalmitis and subretinal 
abscess. Presenting vision was finger counting close to face. Despite prompt initiation of systemic antibiotics and 
intravitreal injection, no response was noted. 25G pars plana vitrectomy was performed along with injection of vanco‑
mycin directly into the subretinal abscess, using a 41G needle. Postoperative course was uneventful and the abscess 
showed signs of rapid resolution. Visual acuity improved to 6/24.
Conclusion: Intralesional pharmacotherapy may be safe and effective in the treatment of subretinal abscess associ‑
ated with endogenous endophthalmitis.
© 2016 The Author(s). This article is distributed under the terms of the Creative Commons Attribution 4.0 International License 
(http://creativecommons.org/licenses/by/4.0/), which permits unrestricted use, distribution, and reproduction in any medium, 
provided you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons license, 
and indicate if changes were made. The Creative Commons Public Domain Dedication waiver (http://creativecommons.org/
publicdomain/zero/1.0/) applies to the data made available in this article, unless otherwise stated.
Background
Endogenous endophthalmitis involves suppurative 
inflammation of the inner ocular coats by an infective 
focus arising from a systemic source. It accounts for 
2–6 % of all endophthalmitis [1]. Subretinal abscess is an 
uncommon presentation and accounts for approximately 
5  % of all endogenous endophthalmitis [2, 3]. It repre-
sents a severe form of the disease and requires appropri-
ate systemic and local treatment [4, 5]. Various treatment 
modalities have been described but no standard manage-
ment guidelines are available. We describe herein man-
agement of subretinal abscess by intralesional antibiotic 
injection using a 41G cannula. To the best of our knowl-
edge such an approach for managing subretinal abscess 
has not been described earlier in published literature.
Case presentation
A 30-year-old female patient presented with complaints 
of sudden onset painful and rapidly progressive diminu-
tion of vision in the left eye of 2 days duration. She gave 
a history of being administered intravenous drugs mul-
tiple times for her episodes of headache over the past 
6 months. There was no history of trauma or ocular sur-
gery. There was no history of any systemic illnesses.
On examination, best corrected visual acuity (BCVA) 
was 6/6 in the right eye and finger counting close to face 
with accurate projection of rays in the left eye. Intraocu-
lar pressure was 13 mmHg in the right eye and 10 mmHg 
in the left eye. On slit lamp biomicroscopy, there was 
mild ciliary congestion, anterior chamber cells of 4+ with 
a hypopyon of approximately 1  mm in the left eye. On 
indirect ophthalmoscopy, there was evidence of 3–4+ 
vitritis. A solitary elevated yellowish lesion could be haz-
ily seen in the superotemporal quadrant giving suspicion 
of an abscess. Combined vector ultrasound B-scan con-
firmed the presence of a subretinal abscess associated 
with vitreous exudates. There was no evidence of retinal 
detachment or choroidal detachment.
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On systemic examination she had evidence of cellu-
litis of the left lower limb. Blood cultures (aerobic and 
anaerobic bacterial and fungal) were sent before initiat-
ing intravenous antibiotics. Results of all other relevant 
investigations were normal.
Based on the clinical picture, a diagnosis of endoge-
nous endophthalmitis with subretinal abscess was made. 
She was started on intravenous Vancomycin (40  mg/
kg/day) and Ceftriaxone (100  mg/kg/day). Pars plana 
vitreous biopsy was performed along with injection of 
intravitreal antibiotics (Vancomycin 1  mg/0.1  ml and 
Ceftazidime 2.25 mg/0.1 ml). Gram stain and culture of 
the vitreous specimen did not reveal any organism. Blood 
culture and urine culture also failed to grow any organ-
ism. There was further deterioration of visual acuity and 
media clarity over the next 24  h along with ultrasound 
evidence of increase in the size of the abscess. A stand-
ard 25G pars plana vitrectomy was hence immediately 
undertaken. After core vitrectomy and sufficient clearing 
of media, a yellowish subretinal abscess of approximately 
8 × 6 disc areas could be visualized in the superotempo-
ral region (Fig. 1a). Since the abscess was large and had 
not responded to systemic and intravitreal injections, 
a decision to administer antibiotics into the lesion was 
taken. An elevated and relatively less vascular area was 
identified over the abscess. 41G needle (DORC inter-
national, Netherlands) was used to inject Vancomycin 
(0.05  mg/0.05  ml) directly into the subretinal abscess 
(Fig.  1b). After air-fluid exchange, silicone oil (1000  cs) 
was injected to provide internal tamponade.
On the first postoperative day, her best corrected visual 
acuity (BCVA) was 4/60. There was a track of exudative 
fluid along the temporal aspect and minimal subreti-
nal bleed adjacent to the abscess (Fig.  1c). On the third 
postoperative day, there was marginal reduction in the 
size of the abscess and appreciable decrease in exuda-
tive fluid. On day 10, after surgery the subretinal abscess 
had shrunk significantly and there was absence of any 
subretinal fluid (Fig.  1d). There was no further increase 
in subretinal hemorrhage. Visual acuity had improved 
to 6/24 at this visit and intraocular pressure was normal 
(13 mmHg). Patient was lost to follow up after this and 
despite repeated telephonic requests did not report for a 
follow up due to economic constraints. She is apparently 
under the care of a local ophthalmologist and continues 
to maintain 6/24 vision in the involved eye.
Conclusion
Endogenous endophthalmitis occurs due to septic embo-
lization of the choroid from a metastatic infectious 
source. Presence of subretinal abscess indicates greater 
severity of the infection and carries high ocular morbid-
ity and systemic mortality [4, 5]. Hence an aggressive 
local and systemic therapy is essential for the control of 
both local disease and systemic condition.
Endogenous endophthalmitis is often seen in patients 
in whom immunity is significantly diminished. How-
ever, immunocompetent individuals with risk factors like 
intravenous drug abuse, long-term intravenous catheteri-
zation, history of gastrointestinal or pelvic surgery, endo-
carditis, abscess in other parts of the body are also prone 
to develop endogenous endophthalmitis [6]. Our patient 
was immunocompetent and there was history of repeated 
intravenous drug administration.
The most common cause of endogenous endophthal-
mitis in drug abusers is fungal [7]. Though we could not 
culture organisms from any of the samples, the rapidity of 
onset and progression favoured a bacterial etiology. The 
presence of cellulitis of the leg also hinted towards the 
possibility of a gram positive organism. Fungal infections 
have only rarely been implicated as a cause of subretinal 
abscess. This is said to be because of their propensity to 
cause vertical invasion across the retina and disseminate 
into the vitreous cavity [8].
In our case, culture of vitreous, blood and urine remained 
negative for both bacterial and fungi. It has been reported 
in the literature that cases of endogenous endophthalmi-
tis presenting as subretinal abscess have low rates of isola-
tion of organisms using aqueous or vitreous biopsy [9, 10]. 
Subretinal biopsy and aspiration has been shown to yield 
higher rates of culture positivity in patients with subretinal 
abscess [11–13]. However, creating retinotomy with con-
ventional techniques in a fragile retina overlying the abscess 
is known to increase the risk of retinal detachment and 
proliferative vitreoretinopathy [10]. Due to this reason and 
the fact that a small (41G) needle was used for intralesional 
drug delivery in our patient, we did not make an attempt at 
diagnostic aspiration of the abscess. This could also be con-
sidered a limitation in our approach and description of the 
case report. A single case and relatively short follow up are 
few other limitations of the report.
No standard management guidelines are available 
in literature for the treatment of a subretinal abscess 
because of its rare occurrence and varied clinical pres-
entation. Management options include intravenous anti-
biotics alone, pars plana vitrectomy with intravitreal 
antibiotics, pars plana vitrectomy with retinotomy or 
retinectomy and enucleation. Intravenous route of antibi-
otic delivery remains the initial modality in the manage-
ment of endogenous endophthalmitis. Trigui et  al. used 
intravenous ceftriaxone alone in the management of a 
subretinal abscess caused by Staphylococcus aureus in a 
diabetic patient with good response [14]. Lakosha et  al. 
had observed incomplete resolution and recurrence of 
the subretinal abscess alone with systemic trimethoprim-
sulfamethoxazole [15].
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A poor response to systemic antibiotic therapy results 
from high choroidal blow and blood retinal barrier which 
allow only 5 % of the administered drug to actually reach 
the intended target. Our patient was started on intrave-
nous antibiotics (Vancomycin and Ceftriaxone) to pro-
vide empirical cover for common bacterial pathogens 
known to cause endogenous endophthalmitis. In case of 
inadequate response to systemic therapy, treatment with 
intravitreal antibiotics has been suggested to provide 
high local concentration of the drug.
Pars plana vitrectomy with intravitreal antibiotics has 
been described as a treatment modality in the management 
of endogenous endophthalmitis. Tsai et  al. have shown 
adequate response to pars plana vitrectomy with intravit-
real injection of Ceftazidime (2 mg/0.1 ml) and Amikacin 
(0.4  mg/0.1  ml) without retinotomy. They inferred that if 
the size of the subretinal abscess is smaller than four disc 
areas, pars plana vitrectomy with intravitreal injection of 
antibiotics could be successful [16]. However, the abscess 
was large in size in our case and we felt that pars plana 
vitrectomy with intravitreal antibiotics alone would not be 
sufficient to reduce the infectious load within the abscess.
In such cases internal drainage of the contents of sub-
retinal abscess using conventional retinotomy has been 
reported [10, 12, 13, 17]. However there was a increased 
incidence of proliferative vitreoretinopathy and retinal 
detachment in these cases [10, 17]. We concur that the 
reason for this increased risk is related the large conven-
tional retinotomy and traction induced by active aspira-
tion. To overcome the complications associated with 
conventional techniques, we opted for a more minimally 
invasive modality. Use of a 41G macular translocation 
needle allowed for a minimally invasive means to deliver 
the drug into the intralesional/subretinal space. We used 
only one drug as we were doing this procedure for the 
first time and were not sure how much of the drug we 
would be able to inject safely into the abscess.
Self-sealing small retinotomy created with a 41G trans-
location needle can be safely used to deliver drugs in a 
subretinal lesion decreasing the chance of proliferative 
Fig. 1 a Intraoperative snap shot of subretinal abscess after performing core vitrectomy (preoperative images could not be obtained due to 
3+/4+ media haze), b intraoperative snapshot showing penetration of the subretinal abscess with 41G needle just before intralesional antibiotic 
injection, c postoperative (day 1) wide angle fundus photograph shows large subretinal abscess, minimal subretinal hemorrhage and significant 
subretinal exudative fluid surrounding the abscess and tracking inferiorly, d postoperative (day 10) fundus photograph shows significant shrinkage 
of the abscess and resolution of the exudative detachment
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vitreoretinopathy and retinal detachment. 41G needle 
has previously been used as a safe modality for subretinal 
delivery of bevacizumab, recombinant tissue plasmino-
gen activator and air in the management of submacular 
bleed associated with wet age related macular degenera-
tion [18].
Subretinal abscess is an extremely rare presentation of 
endogenous endophthalmitis. Both local and systemic 
therapies are important to reduce ocular morbidity and 
systemic morbidity and mortality. A large subretinal 
abscess may require some form of locally invasive ther-
apy. A 41G translocation needle can be safely used in 
such cases to create a self-sealing retinotomy to inject 
intralesional antibiotics.
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